BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 2549225)

  • 1. Kinetic sensitivity of a receptor-binding radiopharmaceutical: technetium-99m galactosyl-neoglycoalbumin.
    Vera DR; Woodle ES; Stadalnik RC
    J Nucl Med; 1989 Sep; 30(9):1519-30. PubMed ID: 2549225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tc-99m galactosyl-neoglycoalbumin: in vitro characterization of receptor-mediated binding.
    Vera DR; Krohn KA; Stadalnik RC; Scheibe PO
    J Nucl Med; 1984 Jul; 25(7):779-87. PubMed ID: 6737077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Technetium-99m galactosyl-neoglycoalbumin: preparation and preclinical studies.
    Vera DR; Stadalnik RC; Krohn KA
    J Nucl Med; 1985 Oct; 26(10):1157-67. PubMed ID: 4045560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in the intracellular processing of the radiolabel following the uptake of iodine-125- and technetium-99m-neogalactosyl albumin by the isolated perfused rat liver.
    Gore S; Morris AI; Gilmore IT; Maltby PJ; Thornback JR; Billington D
    J Nucl Med; 1991 Mar; 32(3):506-11. PubMed ID: 2005461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of (99m)Tc-DMP-NGA as a novel hepatic asialoglycoprotein receptor imaging agent.
    Yang W; Mou T; Zhang X; Wang X
    Appl Radiat Isot; 2010 Jan; 68(1):105-9. PubMed ID: 19815422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tc-99m-galactosyl-neoglycoalbumin: in vivo characterization of receptor-mediated binding to hepatocytes.
    Vera DR; Krohn KA; Stadalnik RC; Scheibe PO
    Radiology; 1984 Apr; 151(1):191-6. PubMed ID: 6701314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gallium-labeled deferoxamine-galactosyl-neoglycoalbumin: a radiopharmaceutical for regional measurement of hepatic receptor biochemistry.
    Vera DR
    J Nucl Med; 1992 Jun; 33(6):1160-6. PubMed ID: 1597732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of receptor concentration and forward-binding rate constant via radiopharmacokinetic modeling of technetium-99m-galactosyl-neoglycoalbumin.
    Vera DR; Stadalnik RC; Trudeau WL; Scheibe PO; Krohn KA
    J Nucl Med; 1991 Jun; 32(6):1169-76. PubMed ID: 2045930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tc-NGA imaging in liver transplantation: preliminary clinical experience.
    Woodle ES; Ward RE; Stadalnik RC; Vera DR
    Surgery; 1989 Mar; 105(3):401-7. PubMed ID: 2646744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative assessment of hepatocellular function through in vivo radioreceptor imaging with technetium 99m galactosyl human serum albumin.
    Kudo M; Todo A; Ikekubo K; Yamamoto K; Vera DR; Stadalnik RC
    Hepatology; 1993 May; 17(5):814-9. PubMed ID: 8491449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of in vivo receptor measurements via in vitro radioassay: technetium-99m-galactosyl-neoglycoalbumin as prototype model.
    Kudo M; Vera DR; Trudeau WL; Stadalnik RC
    J Nucl Med; 1991 Jun; 32(6):1177-82. PubMed ID: 2045931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Technetium-99m NGA functional hepatic imaging: preliminary clinical experience.
    Stadalnik RC; Vera DR; Woodle ES; Trudeau WL; Porter BA; Ward RE; Krohn KA; O'Grady LF
    J Nucl Med; 1985 Nov; 26(11):1233-42. PubMed ID: 2997417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tc-NGA imaging in liver transplantation: preclinical studies.
    Woodle ES; Vera DR; Stadalnik RC; Ward RE
    Surgery; 1987 Jul; 102(1):55-62. PubMed ID: 3296267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic performance of a receptor-binding radiopharmacokinetic model.
    Vera DR; Stadalnik RC; Metz CE; Pimstone NR
    J Nucl Med; 1996 Jan; 37(1):160-4. PubMed ID: 8543988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular metabolic fate of radioactivity after injection of technetium-99m-labeled hydrazino nicotinamide derivatized proteins.
    Ono M; Arano Y; Uehara T; Fujioka Y; Ogawa K; Namba S; Mukai T; Nakayama M; Saji H
    Bioconjug Chem; 1999; 10(3):386-94. PubMed ID: 10346868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Galactosyl neoglycoalbumin:preparation and studies of its binding with hepatic special receptor].
    Pang Q; Yang L; Zhong Y; Guan C; Zhao Q; Tan T
    Hua Xi Yi Ke Da Xue Xue Bao; 1991 Sep; 22(4):368-71. PubMed ID: 1814813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic uptake of [99mTc]galactosyl-neoglycoalbumin is sensitive to receptor quantity.
    Kudo M; Vera DR; Trudeau WL; Stadalnik RC
    Int J Rad Appl Instrum B; 1991; 18(7):663-6. PubMed ID: 1787074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of human hepatic binding protein (HBP) via 99mTc-galactosyl-neoglycoalbumin (NGA) liver scintigraphy.
    Virgolini I; Müller C; Angelberger P; Höbart J; Bergmann H; Sinzinger H
    Wien Klin Wochenschr; 1991; 103(15):458-61. PubMed ID: 1926872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo estimates of hepatic binding protein concentration: correlation with classical indicators of hepatic functional reserve.
    Kudo M; Vera DR; Stadalnik RC; Trudeau WL; Ikekubo K; Todo A
    Am J Gastroenterol; 1990 Sep; 85(9):1142-8. PubMed ID: 2389727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Technetium-99m-galactosyl-neoglycoalbumin combined with iodine-123-Tyr-(A14)-insulin visualizes human hepatocellular carcinomas.
    Kurtaran A; Li SR; Raderer M; Leimer M; Müller C; Pidlich J; Neuhold N; Hübsch P; Angelberger P; Scheithauer W
    J Nucl Med; 1995 Oct; 36(10):1875-81. PubMed ID: 7562058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.